Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans

Neil Hanley, James Pritchett, Emma Harvey, Varinder Athwal, Andrew Berry, Cliff Rowe, Fiona Oakley, Anna Moles, Derek A. Mann, Nicoletta Bobola, Andrew D. Sharrocks, Brian J. Thomson, Abed M. Zaitoun, William L. Irving, Indra N. Guha, Neil A. Hanley, Karen Piper Hanley

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology